Albert Cha
InvestorManaging Partner at Frazier Life Sciences · Chairman at Ascendis Pharma A/S · Board director at Aclaris Therapeutics
Palo Alto
About
Albert Cha is a Managing Partner on Frazier's Life Sciences team, which he co-leads, and co-manages the Frazier Life Sciences Public Fund; he joined the firm in 2021 with over 25 years of experience investing in biopharmaceutical and medical device companies. He was previously a Managing Partner at Vivo Capital and earlier worked at Oracle Corporation in pharmaceutical consulting and at the Palo Alto VA Hospital as a biomedical engineer. He holds B.S. and M.S. degrees in Electrical Engineering from Stanford University and completed the Medical Scientist Training Program at UCLA School of Medicine, earning an M.D. and a Ph.D. in Neuroscience.
Contact· published on Albert's own website
Invests in
BiotechMedical Devices
Board director at Aclaris Therapeutics
Intro paths
In turn, Albert can intro founders to Aclaris Therapeutics's investors below.
Aclaris Therapeutics's investors · 8
Co-founders at Aclaris Therapeutics
Experience
- Frazier Life SciencesManaging Partnercurrent2021 — present
- Ascendis PharmaChairmancurrent2021 — presentCopenhagen, Capital Region of Denmark, Denmark
- KalVista Pharmaceuticals, Inc.Board Member2016 — 2024Cambridge, Massachusetts, United States
- Vivo CapitalManaging Partner2000 — 2020
- OracleConsultant1992 — 1993
Skills & more
+8 more
Financial ModelingManagement ConsultingProduct ManagementProduct DevelopmentM&A experiencePharmaceutical IndustryStrategic PlanningStrategyFrom Albert's professional profile.
Investments
Board seats
Aclaris TherapeuticsAscendis Pharma A/SBiohaven PharmaceuticalsKalVista Pharmaceuticals
Per the firm's website.
Colleagues at Frazier Life Sciences
Network7
Investors connected to Albert in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Albert Cha?
- Albert Cha is a Managing Partner on Frazier's Life Sciences team, which he co-leads, and co-manages the Frazier Life Sciences Public Fund; he joined the firm in 2021 with over 25 years of experience investing in biopharmaceutical and medical device companies. He was previously a Managing Partner at Vivo Capital and earlier worked at Oracle Corporation in pharmaceutical consulting and at the Palo Alto VA Hospital as a biomedical engineer. He holds B.S. and M.S. degrees in Electrical Engineering from Stanford University and completed the Medical Scientist Training Program at UCLA School of Medicine, earning an M.D. and a Ph.D. in Neuroscience.
- Where does Albert Cha work?
- Albert Cha is Managing Partner at Frazier Life Sciences and Board director at Aclaris Therapeutics.
- What does Albert Cha invest in?
- Albert Cha invests in Biotech, Medical Devices.
- What boards does Albert Cha sit on?
- Albert Cha holds tracked board seats at Aclaris Therapeutics, Ascendis Pharma A/S, Biohaven Pharmaceuticals, KalVista Pharmaceuticals.
- Where did Albert Cha go to school?
- Albert Cha studied at Stanford University (M.S., Electrical Engineering); Stanford University (B.S., Electrical Engineering); UCLA (M.D./Ph.D., Neuroscience).
Same school
Also attended Stanford University2,000
+ 1,994 more
Also attended UCLA625
+ 619 more
